UnitedHealth Group is a U.S. multinational for-profit healthcare company focused on health insurance and healthcare services. It operates insurance products under UnitedHealthcare and healthcare service offerings under the Optum brand.
Healthcare stocks were described as a defensive sector facing 2026 reimbursement headwinds, while capex rankings showed HCA Healthcare, Johnson & Johnson and Merck at the top. The sources also highlighted how capex differs across providers, device makers and drug developers.
The FDA is expected to issue draft guidance reducing testing requirements for biosimilar drugs, potentially lowering development costs by USD 20 million. The move comes as the biosimilars market shows strong growth, with major launches in 2025.
Healthcare sector surged 10% since Q4 2025, outpacing all S&P 500 sectors as investors rotate from tech to pharmaceutical value plays. Major drugmakers demonstrate resilience following Medicare price negotiations implementation.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05680623 |
Clinical and Economic Validation of the ISGPS Definition of PPAP |
COMPLETED | |
| NCT05245773 |
MORE-PC: A 30-day Automated SMS Program to Support Post-discharge Transitions of Care |
COMPLETED | NA |
| NCT04810026 |
Transform Type 2: Examining Meal-Delivery and Education for Diabetes Self-Care |
COMPLETED | NA |
| NCT04663061 |
Diabetes Data-Assisted Remission Trial (DDART) |
COMPLETED | NA |
| NCT04510194 |
COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19) |
COMPLETED | PHASE3 |
| NCT04353037 |
PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine |
TERMINATED | PHASE2 |
| NCT04327804 |
A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research |
COMPLETED | |
| NCT04321369 |
Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals |
COMPLETED | |
| NCT03543176 |
Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness |
COMPLETED | |
| NCT03040310 |
Personalized Back Rx Exercise Program as a Treatment for Discogenic Low Back Pain |
COMPLETED | NA |
